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Abstract
The surface-localized M protein of Streptococcus pyogenes is a major virulence factor that inhibits phagocytosis, as
determined ex vivo. Because little is known about the role of M protein in vivo we analyzed the contribution of different M
protein regions to virulence, using the fibrinogen (Fg)-binding M5 protein and a mouse model of acute invasive infection.
This model was suitable, because M5 is required for mouse virulence and binds mouse and human Fg equally well, as
shown here. Mixed infection experiments with wild type bacteria demonstrated that mutants lacking the N-terminal
hypervariable region (HVR) or the Fg-binding B-repeat region were strongly attenuated, while a mutant lacking the
conserved C-repeats was only slightly attenuated. Because the HVR of M5 is not required for phagocytosis resistance, our
data imply that this HVR plays a major but unknown role during acute infection. The B-repeat region is required for
phagocytosis resistance and specifically binds Fg, suggesting that it promotes virulence by binding Fg. However, B-repeat
mutants were attenuated even in Fg-deficient mice, implying that the B-repeats may have a second function, in addition to
Fg-binding. These data demonstrate that two distinct M5 regions, including the HVR, are essential to virulence during the
early stages of an infection. In particular, our data provide the first in vivo evidence that the HVR of an M protein plays a
major role in virulence, focusing interest on the molecular role of this region.
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Introduction
A surface protein of a bacterial pathogen qualifies as a virulence
factor if a mutant lacking this protein is attenuated in an animal
infection model. Although many bacterial proteins fulfill this
criterion, little is known about the contribution to virulence of
different regions within a protein. Here, we study this problem for
the M protein of Streptococcus pyogenes (group A streptococcus), a
major human pathogen [1].
The surface-anchored M protein is a fibrillar molecule that
plays a key role in host colonization and virulence [2–5]. The best
known property of this protein is its ability to inhibit phagocytosis
under nonimmune conditions, i.e. in the absence of opsonizing
antibodies. Evidence for this property was first obtained in classical
ex vivo studies employing whole human blood [6,7]. More recent
ex vivo and in vitro studies have ascribed additional functions to
M protein, including epithelial cell adhesion [8,9], formation of
toxic soluble complexes with fibrinogen (Fg) [10], induction of
T-regulatory cells [11], acquisition of surface-localized plasmin
activity [12], and camouflaging of other bacterial surface
components [13]. However, little is known about the function of
M protein in vivo.
Analysis of the in vivo role of M protein is complicated by the fact
that S. pyogenes is a strict human pathogen, limiting the use of
animal models. Indeed, the best models available for studies of
S. pyogenes may be two ex vivo models employing human material,
the whole blood model [14,15] and an organ culture model
employing tonsillar tissue [16]. However, even ex vivo models have
limitations and the use of animal models is essential [17]. Primate
models for studies of S. pyogenes have been described, but for
obvious reasons they can only be used in certain situations [5,18],
and the mouse remains the system of choice.
We used a mouse infection model to analyze the contribu-
tion to virulence of different regions within an extensively
studied M protein, the M5 protein. Studies of this M protein
were of general interest because many (but not all) M proteins
h a v ep r o p e r t i e ss i m i l a rt oM 5a nd bind human fibrinogen (Fg)
[2,19,20]. Like other M proteins, M5 has an N-terminal
hypervariable region (HVR), which is the target for opsonizing
antibodies, and a C-terminal part that includes a relatively
conserved C-repeat region [2,19]. The region between the
HVR and the C-repeats comprises the B-repeat region, which
binds Fg and is required for phagocytosis resistance, as
determined ex vivo [3,21,22]. We show here that both the
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7279HVR and the B-repeat region of M5 are essential to virulence
during acute infection in mice.
Results
Experimental system: the M5 protein
The M5 protein comprises three well-defined regions: the HVR,
the B-repeats and the C-repeats (Figure 1A). Previous work has
shown that each of these regions binds a human plasma protein.
The HVR binds FHL-1, a splice variant of the complement
regulator factor H (FH) [23]. The role of bound FHL-1 remains
unknown [24,25], and mice do not have FHL-1 (P. Zipfel,
personal communication), implying that any role of the HVR in S.
pyogenes M5 infected mice cannot be explained through binding of
FHL-1. The B-repeat region binds Fg and is required for
phagocytosis resistance, making it the only region in M5 with a
well-defined function, as determined ex vivo [21,22,25]. The C-
repeat region binds albumin [25–27], and also promotes binding
to CD46, a surface-localized complement regulator present on all
human cells [8,11]. It is not known whether M5 and other M
proteins bind CD46 of mouse origin, but even if this were the case,
the limited tissue distribution of CD46 in normal mice [28] makes
it unlikely that the interaction would be of relevance in the mouse
model.
The M5 protein binds human and mouse Fg equally well
Many M proteins bind human plasma proteins in a species
specific manner and do not bind the corresponding mouse
proteins [29,30]. Because an important part of the present project
was focused on Fg-binding, we analyzed whether M5 binds Fg of
different origin (Figure 2A). This analysis showed that M5 binds to
Fg from some but not all species analyzed and binds to both
human and mouse Fg (Figure 2A). Several types of analyses
subsequently demonstrated that mouse and human Fg interact
with M5 in similar ways. First, radiolabeled mouse and human Fg
showed binding to whole M5-expressing bacteria, but not to a
bacterial mutant lacking the entire M5 protein (DM5) or to a
mutant expressing an M5 protein lacking B repeats (DB)
(Figure 2B). Second, western blot analysis with purified prepara-
tions of the M5 and DB proteins showed binding of mouse and
human Fg to M5 but not to DB (Figure S1A). Third, mouse and
human Fg were equally efficient in inhibiting the binding between
human Fg and pure M5 protein, implying that the two Fgs have
the same relative affinity for M5 (Figure S1B and Methods S1).
Finally, M5 expressed on the bacterial surface binds mouse and
human Fg present in plasma, i.e. binding occurs under
physiological conditions. This was demonstrated by incubation
of S. pyogenes in whole plasma, followed by elution of bound
proteins and analysis by western blot (Figure 2C). Bacteria
expressing the wild type M5 protein bound Fg in both mouse
and human plasma, while bacteria expressing the DB protein did
not.
As studies in the human system have indicated that Fg bound to
M5 inhibits complement deposition [22], we analyzed whether Fg
has this property also in the mouse system. When M5-expressing
bacteria were incubated in mouse serum, i.e. in the absence of Fg,
complement was deposited on the bacterial surface, but addition of
pure mouse Fg at physiological concentration caused an ,6-fold
reduction in deposition (Figure S2 and Methods S1). In contrast,
complement deposition on the DB strain was only slightly affected
by the addition of Fg. Thus, binding of Fg to M5 inhibits
complement deposition in the mouse system, confirming that the
mouse model is suitable for studies of Fg-binding to M5.
Mouse infections
The contribution of intact M5 to bacterial virulence was first
analyzed. Mice were infected with an ,LD90 dose of M5-
expressing wild type bacteria or a mutant (DM5) lacking the entire
M5 protein. All mice infected with wild type bacteria succumbed
to infection, whereas all mice in the group infected with the DM5
mutant survived (Figure 3A). These data indicate that the M5
protein is a major virulence factor in this model of lethal infection.
The contribution of different M5 regions to virulence was
analyzed in a mixed infection model [31], employing a series of
previously characterized chromosomal in frame deletions [22,25]
corresponding to the entire surface-exposed region of M5
(Figure 1A). The previous studies had shown that the truncated
M5 proteins encoded by these mutants are expressed in normal
amounts on the S. pyogenes surface and have the expected binding
properties (Figure 1B). In particular, a deletion only abolishes
ligand binding to the corresponding region but not to adjacent
regions. Moreover, deletions in the HVR have little or no effect on
the ability of the B-repeat region to promote phagocytosis
resistance [25]. Together, these data imply that the mutants can
be used to analyze the contribution of different M5 regions to
mouse virulence.
The mixed infection experiments employed a ,1:1 mixture of
mutant and wild type strain. Infected mice were sacrificed after
,44 hours and extracts of spleens and livers were analyzed for the
ratio between the two strains present in the inoculum, allowing
calculation of a competitive index (CI). Of note, these experiments
analyzed virulence during the early stages of an infection and
under nonimmune conditions.
Figure 1. Schematic representation of the M5 protein and its
ligand binding properties. (A) The M5 protein can be divided into
three distinct regions: the N-terminal hypervariable region (HVR), the B-
repeat region and the C-repeat region [19]. Each of these regions binds
a human plasma protein, as indicated. In-frame deletions in the
chromosomal emm5 gene results in expression of the DN1, DN2, DB,
and DC deletion variants. After removal of the signal peptide, M5 has a
total length of 450 aa residues. Part of the C-repeat region and the C-
terminal region are probably hidden in the bacterial cell wall [2]. The
numbers indicate aa residues in the processed form of M5. FHL-1, factor
H-like protein 1; Fg, fibrinogen. Adapted from refs. [22] and [25]. (B)
Ligand binding properties of bacterial mutants used in this study. The
DN1 and DN2 mutants do not bind FHL-1, the DB mutant does not bind
Fg and the DC mutant is unable to bind albumin, while the regions not
deleted in these mutants retain their ligand-binding properties. Based
on data in ref. [25].
doi:10.1371/journal.pone.0007279.g001
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When mixed infection analysis was performed with the DM5
strain, which lacks the entire M5 protein, almost all of the
recovered bacteria were wild type in both spleen and liver extracts
(Figure 3B). These results indicate that the M5 protein is essential
for virulence in this model and confirm the data obtained in the
model of lethal infection (Figure 3A).
Analysis of the DN1 strain, which lacks most of the N-terminal
part of the HVR, showed that also this strain was strongly
attenuated, implying that the HVR is important for virulence.
Similar results were obtained with a second independent HVR
mutant, DN2, which lacks the C-terminal part of the HVR
(Figure 3B). This result with DN2 excludes the possibility that the
results obtained with DN1 were due to a second mutation,
inadvertently introduced during mutant construction. Together,
these data on DN1 and DN2 suggest that not only the N-terminal
but also the C-terminal part of the M5 HVR plays a major role in
virulence.
Mixed infection with the DB strain showed that it was as
attenuated as the DM5 strain (Figure 3B), indicating that the B-
repeat region is essential for virulence. Similar results were
obtained with another shorter B-region deletion mutant in which
only the C-terminal part of the B-repeat region was missing,
leaving the first repeat intact, but abolishing Fg-binding (data not
shown). These results in mixed infection experiments with the B
region mutants were not unexpected, given the extensive data
showing that this region of M5 binds Fg and is required for
phagocytosis resistance ex vivo [21,22,25].
The DC strain, which lacks the entire C-repeat region, was only
slightly attenuated in mixed infections, and results obtained for the
spleen were not statistically significant. Thus, the C-repeats are of
limited importance for virulence in this model (Figure 3B). Of
note, the results obtained with the C-repeat mutant demonstrate
that attenuation in the mixed infection model is not caused by any
long deletion in the emm5 gene.
Role of the B-repeat region in virulence: analysis with Fg-
deficient mice
The finding that the B-repeat region is essential to virulence
could most simply be explained by the ability of this region to bind
Fg, which has been implicated in phagocytosis resistance [22,32].
In an attempt to obtain conclusive evidence for this hypothesis we
Figure 2. Analysis of the interaction between the M5 protein and Fg. (A) Ability of the M5 protein to bind Fgs of different origin. The
immobilized Fgs were analyzed in a dot-blot, using
125I-labeled M5 protein as the probe. (B) Binding of
125I-labeled mouse and human Fg to S.
pyogenes, as a function of bacterial concentration. M5, wild type S. pyogenes M5 Manfredo; DB, bacterial mutant lacking the B repeat region; DM5,
mutant lacking the entire M5 protein. Maximum binding was defined as 100%. The data represent mean values with SD from three experiments with
triplicate samples. (C) Ability of M5-expressing bacteria to bind Fg present in whole mouse plasma (left) or human plasma (right). Washed S. pyogenes
bacteria from an overnight culture were incubated with plasma. Bacteria-bound proteins were eluted and analyzed by western blot, using antibodies
against mouse or human Fg as the probe. Bound antibodies were detected by incubation with radiolabeled protein G, followed by autoradiography.
As controls, whole plasma and pure Fg were included in each analysis, as indicated. This analysis was performed twice, with similar results.
doi:10.1371/journal.pone.0007279.g002
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infection. Groups of 15 mice were infected i.p. with M5 wild type bacteria or the DM5 mutant. Each mouse received 3610
7 cfu, which corresponded
to an ,LD90 dose of wild type bacteria. (B) Mixed infection experiments with S. pyogenes mutants lacking different regions of the surface-localized M5
protein. Groups of 5 C3H/HeN mice were infected i.p. with a 1:1 mixture of mutant and wild type bacteria, as indicated. Surviving animals (n=3–5)
were sacrificed after 44 h and spleens and livers were analyzed for presence of the two strains present in the input. Results are presented as
competitive index (CI), which is defined as the ratio between mutant and wild type in the output divided by the same ratio in the input. Student’s t-
test was used for statistical analysis, in which the ratio in the input was compared with that in the output. The results were statistically significant in all
cases except the spleens from mice infected with a mixture of DC and M5. ***=p,0.001; n.s., not significant. (C) Mixed infection experiments with
Fg-deficient mice (on Balb/c background). Groups of 4 mice were infected with a 1:1 mixture of either the DB mutant and wild type bacteria, or the
DB234 mutant and wild type bacteria, as indicated. The deletion in the DB mutant covers the entire B-repeat region, while the shorter deletion in the
DB234 mutant does not include the first B-repeat. The mice were sacrificed after 20 h. Analysis was performed as described in B. ***=p,0.001.
doi:10.1371/journal.pone.0007279.g003
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infection studies [33,34]. We expected that mixed infection with
the DB mutant in Fg-deficient mice would result in similar growth
for wild type bacteria and mutant, because the wild type no longer
would be able to recruit Fg. Such a result would prove that the B-
repeat region contributes to virulence by recruiting Fg.
If bacteria-bound Fg contributesto virulence, one might expect Fg-
deficient mice to be more resistant than wild type mice to S. pyogenes
infection, because Fg no longer could be exploited to promote
virulence. However, preliminary experiments suggested that the S.
pyogenes M5 strain studied here multiplied equally well in wild type
and Fg-deficient mice, at least during the early stages of an infection.
This result may reflect the homeostatic imbalance in Fg-deficient
mice, causing a general increase in sensitivity to infection [33,34].
Indeed, Fg-deficient mice showed increased sensitivity to S. pyogenes in
a recent study employing a hypervirulent bacterial mutant [35].
Surprisingly, mixed infection experiments showed that the DB
mutant was severely attenuated also in Fg-deficient mice
(Figure 3C). Because the deletion in this mutant does not affect
the known binding properties of surrounding regions in M5 ([25];
Figure 1B), it seemed unlikely that this result could be explained by
an indirect effect. Nevertheless, we explored this possibility by
analyzing the second B region deletion mutant described above, in
which only the C-terminal part of the B-repeat region is missing.
Like DB, this mutant (designated DB234) was attenuated in Fg-
deficient mice (Figure 3C).
Because the B-repeat mutants were attenuated even in Fg-
deficient mice, lack of Fg-binding is not sufficient to explain the
properties of the mutants. The reason for this result remains
unclear but might be explained if the B-repeats not only bind Fg
but also bind a second ligand implicated in virulence, causing
attenuation of mutants even in Fg-deficient mice.
Binding properties of the B-repeat region
To analyze whether the B-repeat region binds a second host
ligand, we analyzed the binding properties of this region in isolated
form. For this purpose, we used a GST fusion protein that includes
the entire 91-residue B-repeat region (Figure 4A). The binding
properties of this protein, designated GST-M5B, were analyzed by
passing whole plasma, of mouse or human origin, through a column
containing the immobilized pure fusion protein. A column
containing only GST was used as control. After washes, bound
proteins were eluted and analyzed by SDS-PAGE. Eluates from the
fusion protein columns only contained material that migrated like
pure Fg (Figure 4B), and this material was confirmed to be Fg by
western blot analysis (data not shown). These results indicate that
the B-repeat region of M5 represents a distinct ligand-binding
domain that only binds Fg among all plasma proteins, but are also
compatible with the hypothesis that a second ligand for the B-
repeats is present in tissues. However, extensive attempts to identify
such a second ligand were unsuccessful (our unpublished data).
Discussion
We used a mouse model to analyze the contribution to virulence
of different regions in the S. pyogenes M5 protein. Studies of this M
protein were of particular interest, because strains expressing M5
have been associated with rheumatic fever, which remains a major
global health problem [1]. Moreover, M5 has properties similar to
many other Fg-binding M proteins. At least with regard to Fg-
binding, the mouse was a suitable model for in vivo studies of M5,
because M5 binds human and mouse Fg equally well. Our results
provide novel, and partly unexpected, information on the role of
the HVR and the Fg-binding B-repeat region in M5.
InconsideringtheroleoftheHVRinanMprotein,itisimportant
to note that the HVR cannot act only as the target for protective
antibodies, but must also have an important function in the absence
of protective immunity, otherwise the HVR would be eliminated by
mutation. This argument does not imply that the HVR is required
during acute infection, because the HVR could promote bacterial
growth at later stages of an infection. For example, the HVR could
act as a decoy that diverts the antibody response from other regions
of the M protein or it could protect another surface component from
immune attack through camouflage [13]. However, the data
reported here clearly show that the HVR of M5 has an essential
role during the early stages of an infection.
It has been proposed that the HVR of an M protein causes
electrostatic repulsion of phagocytes, thereby promoting phago-
cytosis resistance [2,36]. However, this model cannot explain the
role of the HVR in M5, because the HVR of this M protein is not
required for phagocytosis resistance [25]. Moreover, the require-
ment of the HVR in M5 for virulence cannot be explained by its
ability to bind FHL-1 [23], because FHL-1 is not found in mice (P.
Zipfel, personal communication). Thus, the molecular role in
virulence of the HVR in M5 remains unknown.
In many M proteins the HVR specifically binds the human
complement inhibitor C4BP, which contributes to phagocytosis
resistance, as determined ex vivo [20,37,38]. Importantly, these
C4BP-binding M proteins do not bind Fg, but C4BP bound to the
Figure 4. The B repeat region of M5 specifically binds Fg. (A)
The aa sequence of the repeats in the Fg-binding B repeat region is
shown, with identical residues indicated by a dot. The total length of
the B repeat region is 91 aa [19]. (B) Affinity chromatography of mouse
plasma (left) and human plasma (right) on a fusion protein derived from
GST and the B repeat region of M5 (GST-M5B). The fusion protein was
bound to glutathione in a column. A column containing only GST was
used as control. Bound proteins were eluted and analyzed by SDS-
PAGE. For comparison, pure Fg of mouse or human origin was included
in the electrophoretic analysis. The ,340 kDa Fg protein contains two
Aa, two Bb and two c chains in both human and mouse Fg [48]. The
positions of the three Fg chains are indicated. For clarity, the lower
parts of the gels, containing eluted GST-M5B or GST but no other
proteins, are not shown. These experiments were performed at least
twice, with very similar results.
doi:10.1371/journal.pone.0007279.g004
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resistance as Fg bound to the B-repeats of M5 [22]. Because many
M proteins have HVRs that bind C4BP, we hypothesize that the
HVR of M5 and similar Fg-binding M proteins also binds a host
component. For example, the HVR of M5 may be required for
binding to a receptor on epithelial cells. This hypothesis implies
that the sequence variability in the HVRs of M5 and related M
proteins may be limited by structural constraints, as must be the
case for C4BP-binding HVRs [38,39]. However, structural
constraints in the HVRs that do not bind C4BP may be less
severe than in those binding C4BP, as judged by analysis of
diversifying selection [40] and by the demonstration of extensive
subtype variation among clinical isolates [41].
A major part of this study was focused on the role of the Fg-
binding B-repeats in M5. Mixed infections indicated that the B-
repeat region plays a key role in virulence, as expected from its
essential role in phagocytosis resistance [21,22,25]. This finding
suggested that the B-repeats promote virulence by binding Fg,
which inhibits complement deposition, but studies with Fg-
deficient mice did not support this simple explanation. In contrast,
our data suggest that the B-repeats not only bind Fg but also have
a second and unknown role in virulence, e.g. through binding a
second host ligand. This putative ligand is probably not a plasma
protein, because our analysis indicated that the B-repeat region
only binds Fg among all human plasma proteins. Thus, our data
indicate that the B-repeat region plays a key role in virulence,
while the role of Fg-binding remains unclear. This results
underscores the difficulties involved in identifying the in vivo role
of a plasma protein bound to an M protein. Indeed, the only clear
evidence that a bound human plasma protein contributes to
S. pyogenes virulence comes from studies, in a transgenic mouse
model, of a plasminogen-binding M protein expressed by a
minority of clinical isolates [42,43].
For understanding of the function of the M5 protein, it is
instructive to compare the virulence data reported here with known
data on phagocytosis resistance and opsonization in the M5 system
(Figure 5). Mouse virulence requires the HVR and the B-repeats, as
shown here. In contrast, only the B-repeat region is required for
phagocytosis resistance, as determined ex vivo [22,25]. Nevertheless,
only antibodies to the HVR have opsonizing capacity in the ex vivo
phagocytosis system [25]. The region in M5 that promotes
phagocytosis resistance is therefore distinct from the region targeted
by opsonizing antibodies. It may seem paradoxical that antibodies
to the HVR are opsonizing, although the HVR is not required for
phagocytosis resistance, but this finding may be explained by the
surface-distal location of the HVR. In vivo, antibodies to the HVR
may also confer protection by blocking the essential function of this
region. The lack of opsonization by antibodies to the B- and C-
repeat regions may be explained by the ability of bound human
plasma proteins to block antibody access to these regions [25].
Together, these comparisons indicate that the three regions in M5
have distinct functions and properties.
In summary, we used a mouse infection model to analyze the
contribution to virulence of three different regions in M5, a major
bacterial virulence factor. Our data indicate that two of the M5
regions, the HVR and the B-repeats, contribute to virulence, while the
C-repeats play a minor role, at least in the acute infection model used
here.Thus, further studies aimed at identification of the in vivo function
of the HVR and the B-repeats will be important for understanding of
S. pyogenes pathogenesis. Such studies will also be of interest for vaccine
development, because constructs derived from HVRs are being
evaluated for ability to elicit protective immunity in humans [44].
Methods
Bacterial strains, media and plasmids
S. pyogenes strain M5 Manfredo, a clinical isolate recovered from
a patient with rheumatic fever [19], was obtained from Dr. M.A.
Kehoe. The M5-negative mutant DM5 has been described [23].
The isogenic mutants DN1, DN2, DB and DC [22,25] carry in-
frame chromosomal deletions corresponding to aa 11–59, 62–110,
118–210 and 215–312, respectively, in the mature M5 protein.
Note that the positions of these deletions differ slightly from the
regions identified in M5 (Figure 1A). A shorter chromosomal B-
region mutant corresponding to aa 143–210 and covering the B2–
B4’ repeats, but not the B1 repeat, was constructed using
previously described procedures [22]. All strains were grown in
Todd-Hewitt broth supplemented with 0.2% yeast extract (THY)
in 5% CO2 at 37uC without shaking.
Proteins and antisera
The M5protein was purified after expression in E. coli, using whole
cell lysates and a combination of ion exchange chromatography and
gel filtration, as described for other members of the M protein family
[45]. The DB derivative of the M5 protein was purified by a similar
procedure, using an E. coli strain carrying a pUC19 derivative
encoding that protein. Protein G was from Amersham Biosciences
(Uppsala, Sweden). Pure human Fg was from Enzyme Research
(Swansea, U.K.). Animal Fgs were from Sigma-Aldrich (St. Louis,
MO). Goat anti-mouse Fg was from Nordic Immunological
Laboratories (Tilburg, The Netherlands). Rabbit anti-human Fg
was from DakoCytomation (Glostrup, Denmark). Antisera specific
for different regions of M5 have been described [25], except for one
directed against the N2 region, which was prepared by absorbing an
antiserum raised against the entire HVR with DN2 bacteria.
Affinity chromatography on the fusion protein GST-M5B
For construction of the fusion protein GST-M5B, a region
corresponding to aa 118–210 in the mature M5 protein was
amplified by PCR from S. pyogenes M5 Manfredo. This M5 region
corresponds to the entire 91-residue B-repeat region and two
additional aa located immediately after the B-repeats. The PCR
fragment was introduced into pGEX-6P-2 (Amersham, Uppsala,
Sweden), yielding the expression vector pGEX-M5B, which
included an introduced stop codon. The sequence of the construct
Figure 5. Properties of different regions in the M5 protein. This
figure summarizes the role of different M5 regions in mouse virulence,
phagocytosis resistance, and opsonization by antibodies. The data on
mouse virulence are from this report, while the data on phagocytosis
resistance and opsonization are from refs. [22] and [25]. Note that the
phagocytosis and opsonization data are based on ex vivo assays. ++,
major role; (+), very limited role; 2, no role; n.a., not analyzed.
doi:10.1371/journal.pone.0007279.g005
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was purified according to the manufacturer’s instructions and
dialyzed against PBS. This protein was homogeneous and of the
expected size, as judged by SDS-PAGE.
For affinity chromatography, the GST-M5B fusion protein
(1 mg) was immobilized in a 1 ml GSTrap column (Amersham)
and 0.5 ml human or mouse plasma (diluted 5-fold in TBS) was
applied. Hirudin (Refludan; Schering; 140 U/ml) was used as anti-
coagulant. The column was washed with TBS (10 ml) and bound
proteins (including GST-M5B) were eluted with TBS containing
20 mM glutathione. The eluate was analyzed by SDS-PAGE. As a
control, plasma was applied to a column containing GST.
Mice
Unless otherwise stated, infection experiments employed 8- to
11-week-old C3H/HeN mice, bred in the animal facility at the
Medical Faculty of Lund University and maintained under
pathogen-free conditions. The Fg-deficient mice used here were
generated by targeted inactivation of the murine Fg c chain [34],
followed by crossbreeding of the resulting C57Bl/6 mice for 10
generations with Balb/c mice. All animal experiments were
approved by the Lund/Malmo ¨ review board on animal studies
and conformed to relevant regulatory standards.
Analysis of mouse lethality
Samples of a log-phase culture of the S. pyogenes strain indicated
were used for i.p. infection of C3H/HeN mice. Each mouse
received 3610
7 cfu (diluted in THY), which represented an
,LD90 dose for the wild type bacteria. (Note that this dose of wild
type bacteria was twice as high as that used in the mixed infection
experiments described below, explaining the lethality.) Deaths
were recorded regularly for 96 h.
Mixed infection experiments
Groupsof5C3H/HeNmicewereinfectedi.p.with a1:1mixture
of log-phase M5 wild type bacteria and one of the mutants DM5,
DN1, DN2, DBo rDC. This mixture was defined as the input. Each
mouse received a total of ,3610
7 cfu. Surviving mice (n=3–5)
were sacrificed after 44 hours and spleens and livers were collected.
The organs were homogenized and samples were plated on blood
agar. The bacteria in these samples, defined as the output, were
analyzed for presence of the two strains present in the input. For
each organ, a total of 270–450 colonies were picked and grown in
short patches on THY agar plates, followed by phenotypic analysis
by blotting analysis. For this purpose, a Petri dish-shaped paper
(referred to as membrane below) was placed on the patches for
,10 min, followed by incubation in a blocking solution (50 mM
Tris-HCl pH 8.0 with 150 mM NaCl and 0.25% gelatin) for 1 h.
After washes with TBS, the membrane was incubated for 1 h with
the appropriate rabbit antiserum, diluted in TBS containing 0.25%
gelatin. The antiserum was directed against an M5 region absent in
the mutant strain of the input, allowing distinction between wild
type and mutant bacteria. After incubation with antiserum, the
membrane was washed with TBS containing 0.05% Tween-20
(TBS-T). Bound antibodies were detected by incubation of the
membrane in a solution containing
125I-labeled protein G, followed
by autoradiography. As controls, each membrane in the analysis
included M5 wild type bacteria and the mutant employed in the
input. All incubations were performed at RT with gentle shaking.
To determine the exact ratio of wild type bacteria and mutant
bacteria in the input, 270 colonies were picked and analyzed by
blotting,asdescribed above.The competitiveindex(CI)wasdefined
as the ratio between mutant and wild type in the output divided by
the same ratio in the input [31].
Mixed infection experiments in Fg-deficient mice were
performed as described above, except that spleens and livers were
harvested after 20 h.
Statistical analysis
Competitive indices (CIs) derived from mixed infection
experiments were analyzed with Student’s t-test. Data from mouse
lethality studies were analyzed with Fischer’s exact test.
Other methods
Dot blot and Western blot analysis were performed as described
[46]. Binding assays with whole washed bacteria and radiolabeled
ligands were performed essentially as described [47]. Maximal
binding (defined as 100%) was ,20% for human Fg and ,50%
for mouse Fg; such variability in maximal binding is commonly
seen in work with radiolabeled proteins and reflects differences in
sensitivity to the
125I-labeling procedure. Plasma absorption assays
with whole washed bacteria were performed essentially as
described [23], with hirudin as anti-coagulant.
Supporting Information
Figure S1 Analysis of the interaction between the M5 protein
and Fg. A) Western blot analysis with the purified M5 and DB
proteins, using
125I-labeled mouse or human Fg as the probe. B)
Inhibition of the interaction between human Fg and M5 protein.
Human Fg was immobilized in microtiter wells, followed by
addition of a mixture of radiolabeled M5 protein and inhibitor
(mouse or human Fg). The final concentration of the inhibitor is
indicated on the X-axis. Binding of M5 protein in the absence of
inhibitor was defined as 100%. These data represent mean values
with SD from three experiments with triplicate samples.
Found at: doi:10.1371/journal.pone.0007279.s001 (3.87 MB TIF)
Figure S2 Mouse Fg bound to the B repeat region of M5 inhibits
complement deposition on the bacterial surface. Samples of M5
wild-type bacteria or DB mutant bacteria were incubated in mouse
serum, or in mouse serum supplemented with mouse Fg, as
indicated. Deposition of C3 on the bacterial surface was detected
with a FITC-conjugated antibody directed against mouse C3. The
data presented to the left represent mean values, with SD, from
three experiments. Deposition on the M5 wild-type strain
incubated in serum was defined as 1.00. A representative
histogram from one experiment is presented to the right. Blue
line, M5 bacteria incubated in mouse serum; black line, M5
bacteria incubated in serum supplemented with Fg; green line, DB
bacteria incubated in serum; red line, DB bacteria incubated in
serum supplemented with Fg. IC, isotype control.
Found at: doi:10.1371/journal.pone.0007279.s002 (1.81 MB TIF)
Methods S1 Contains protocols for the inhibition test in Figure
S1B and the analysis of complement deposition in Figure S2.
Found at: doi:10.1371/journal.pone.0007279.s003 (0.03 MB
DOC)
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